Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus
about
Molecular epidemiology and phylogeny reveal complex spatial dynamics in areas where canine parvovirus is endemic.First detection of canine parvovirus type 2c in BrazilIdentification of a novel canine parvovirus type 2c in Taiwan.Genotyping and pathobiologic characterization of canine parvovirus circulating in Nanjing, ChinaDuration of immunity induced by companion animal vaccines.First molecular characterization of canine parvovirus strains in Sardinia, Italy.Efficacy of feline anti-parvovirus antibodies in the treatment of canine parvovirus infection.Canine parvovirus in vaccinated dogs: a field study.Canine parvovirus type 2c identified from an outbreak of severe gastroenteritis in a litter in Sweden.Canine parvovirus: current perspective.Development and evaluation of loop-mediated isothermal amplification assay for rapid and sensitive detection of canine parvovirus DNA directly in faecal specimens.Vaccination of dogs with Duramune DAPPi+LC protects against pathogenic canine parvovirus type 2c challenge.Fecal microbiota transplantation in puppies with canine parvovirus infection.Canine parvovirus 2c infection in central Portugal.Effects of subclinical inflammation on C-reactive protein and haptoglobin levels as well as specific humoral immunity in dogs vaccinated against canine distemper and parvovirus.Characterization of Canine Parvovirus 2 Variants Circulating in Greece
P2860
Q35140255-B409EB0C-93DF-4A15-B891-20CE65036EADQ37159368-F4471F3D-46A8-491D-A6C5-8D6CFCC76F9CQ37280781-BFCFE2F0-75C7-4F2E-9D8D-AE73206CB617Q37351719-62B79F3D-AAD6-4962-9E53-AAAECE5564A8Q37804487-F2AB9489-3D08-4DE8-95A1-3A27A2C617A9Q40123154-B6B711E1-640B-4879-B017-42E96BA167A2Q40261507-AD0275CA-9D28-4BA5-95BE-D8B1C63ACF49Q40761405-DB1CF268-7DE1-49A5-96F5-840DC3C79158Q41952885-58C9E467-1343-475C-BD41-33E1355EB83DQ42880961-41008AE6-F7F3-4463-8E83-17AB07E6BBA1Q43500295-6CF292C3-7450-4B92-B30D-9BBB0CFABFF2Q44891510-F6E709B7-82D3-43F4-8EC9-18463DED14A0Q49823404-02D1226E-6A50-4046-8E95-8BB277902E23Q52804436-BC8CC4CF-0143-4A7B-B292-D6D979D2B706Q54262016-55A56A51-5FE1-4B0B-A8E6-565180D297FAQ57584501-D621CDCE-8B69-431D-BAEA-61DE117826C0
P2860
Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus
@ast
Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus
@en
Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus
@nl
type
label
Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus
@ast
Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus
@en
Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus
@nl
prefLabel
Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus
@ast
Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus
@en
Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus
@nl
P2093
P3181
P1476
Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus
@en
P2093
N M Greenwood
W S K Chalmers
P3181
P356
10.1016/J.VETMIC.2007.09.015
P407
P577
2008-04-01T00:00:00Z